Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Molecular Therapy - Oncolytics | journal | 1.494 Q1 | 42 | 97 | 488 | 5554 | 2595 | 478 | 5.35 | 57.26 | |
52 | Vaccines | journal | 1.201 Q1 | 85 | 1854 | 4462 | 105389 | 22996 | 4375 | 5.37 | 56.84 | |
53 | Pharmaceutical Research | journal | 0.707 Q2 | 229 | 223 | 633 | 12655 | 2336 | 624 | 3.55 | 56.75 | |
54 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.220 Q1 | 47 | 43 | 142 | 2437 | 622 | 142 | 4.21 | 56.67 | |
55 | Journal of Psychiatry and Neuroscience | journal | 1.317 Q1 | 114 | 55 | 178 | 3072 | 615 | 142 | 3.13 | 55.85 | |
56 | Journal of Dietary Supplements | journal | 0.590 Q2 | 38 | 66 | 148 | 3678 | 459 | 144 | 3.13 | 55.73 | |
57 | OncoTargets and Therapy | journal | 0.810 Q2 | 86 | 77 | 1693 | 4228 | 5625 | 1685 | 2.67 | 54.91 | |
58 | Journal of Cardiovascular Development and Disease | journal | 0.621 Q2 | 32 | 497 | 709 | 27150 | 1727 | 700 | 2.40 | 54.63 | |
59 | Cancer Innovation | journal | 0.389 Q3 | 4 | 56 | 20 | 3056 | 23 | 19 | 1.15 | 54.57 | |
60 | Reviews on Clinical Pharmacology and Drug Therapy | journal | 0.139 Q4 | 5 | 30 | 120 | 1629 | 33 | 120 | 0.27 | 54.30 | |
61 | Open Access Journal of Clinical Trials | journal | 0.561 Q2 | 15 | 1 | 15 | 54 | 31 | 14 | 1.11 | 54.00 | |
62 | npj Vaccines | journal | 2.127 Q1 | 47 | 182 | 421 | 9795 | 2689 | 404 | 6.60 | 53.82 | |
63 | Human Psychopharmacology | journal | 0.541 Q3 | 86 | 23 | 117 | 1225 | 246 | 116 | 1.98 | 53.26 | |
64 | International Journal of Neuropsychopharmacology | journal | 1.525 Q1 | 125 | 79 | 261 | 4188 | 1265 | 254 | 4.59 | 53.01 | |
65 | Experimental and Clinical Psychopharmacology | journal | 0.827 Q2 | 101 | 63 | 309 | 3335 | 740 | 308 | 2.43 | 52.94 | |
66 | Journal of Applied Pharmaceutical Science | journal | 0.258 Q3 | 56 | 276 | 696 | 14302 | 945 | 695 | 1.23 | 51.82 | |
67 | Cannabis and Cannabinoid Research | journal | 0.932 Q1 | 42 | 173 | 194 | 8890 | 873 | 183 | 4.16 | 51.39 | |
68 | Drug and Alcohol Dependence | journal | 1.632 Q1 | 187 | 333 | 1656 | 16964 | 6722 | 1617 | 3.94 | 50.94 | |
69 | Expert Opinion on Drug Safety | journal | 0.905 Q1 | 90 | 165 | 441 | 8337 | 1384 | 401 | 3.03 | 50.53 | |
70 | Journal of Psychedelic Studies | journal | 0.503 Q3 | 12 | 37 | 43 | 1858 | 116 | 43 | 2.68 | 50.22 | |
71 | American Journal of Cardiovascular Drugs | journal | 0.790 Q2 | 60 | 60 | 184 | 2987 | 512 | 174 | 2.66 | 49.78 | |
72 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.696 Q2 | 57 | 27 | 169 | 1330 | 433 | 166 | 2.60 | 49.26 | |
73 | Contemporary Clinical Trials | journal | 0.980 Q1 | 75 | 268 | 776 | 13039 | 1813 | 763 | 2.24 | 48.65 | |
74 | Clinical Psychopharmacology and Neuroscience | journal | 0.802 Q2 | 42 | 66 | 242 | 3193 | 652 | 237 | 2.33 | 48.38 | |
75 | Pharmacotherapy | journal | 0.943 Q1 | 126 | 123 | 305 | 5918 | 1029 | 286 | 3.02 | 48.11 | |
76 | Biopharmaceutics and Drug Disposition | journal | 0.396 Q3 | 65 | 36 | 91 | 1728 | 188 | 89 | 1.91 | 48.00 | |
77 | Therapeutic Advances in Drug Safety | journal | 1.035 Q1 | 46 | 27 | 103 | 1296 | 396 | 91 | 3.07 | 48.00 | |
78 | Recent Advances in Anti-Infective Drug Discovery | journal | 0.203 Q3 | 38 | 18 | 53 | 861 | 58 | 50 | 1.07 | 47.83 | |
79 | Indonesian Journal of Pharmacy | journal | 0.199 Q3 | 10 | 50 | 156 | 2376 | 145 | 156 | 0.86 | 47.52 | |
80 | Chinese Herbal Medicines | journal | 0.572 Q2 | 18 | 88 | 160 | 4158 | 570 | 151 | 3.53 | 47.25 | |
81 | Cardiovascular Drugs and Therapy | journal | 0.973 Q1 | 79 | 227 | 345 | 10672 | 1131 | 312 | 3.13 | 47.01 | |
82 | Current Signal Transduction Therapy | journal | 0.188 Q3 | 22 | 20 | 80 | 940 | 47 | 71 | 0.58 | 47.00 | |
83 | Chinese Journal of Integrative Medicine | journal | 0.502 Q3 | 44 | 155 | 414 | 7284 | 1062 | 404 | 2.22 | 46.99 | |
84 | Therapeutic Advances in Respiratory Disease | journal | 1.179 Q1 | 50 | 78 | 206 | 3651 | 791 | 194 | 3.55 | 46.81 | |
85 | Nanomedicine Research Journal | journal | 0.304 Q3 | 20 | 39 | 120 | 1819 | 243 | 120 | 1.85 | 46.64 | |
86 | Farmatsiya i Farmakologiya | journal | 0.146 Q4 | 7 | 34 | 129 | 1584 | 69 | 129 | 0.50 | 46.59 | |
87 | Therapeutics and Clinical Risk Management | journal | 0.752 Q2 | 70 | 90 | 357 | 4189 | 986 | 352 | 2.35 | 46.54 | |
88 | Drug Metabolism and Personalized Therapy | journal | 0.267 Q3 | 38 | 46 | 137 | 2138 | 142 | 134 | 0.97 | 46.48 | |
89 | Pharmacopsychiatry | journal | 0.834 Q2 | 84 | 35 | 99 | 1621 | 294 | 84 | 3.42 | 46.31 | |
90 | European Neuropsychopharmacology | journal | 1.756 Q1 | 130 | 134 | 450 | 6187 | 2034 | 346 | 4.22 | 46.17 | |
91 | Antimicrobial Resistance and Infection Control | journal | 1.256 Q1 | 66 | 143 | 522 | 6549 | 2764 | 509 | 4.86 | 45.80 | |
92 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 41 | 153 | 1868 | 578 | 152 | 3.76 | 45.56 | |
93 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | journal | 0.571 Q2 | 81 | 36 | 120 | 1613 | 374 | 110 | 1.73 | 44.81 | |
94 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.671 Q2 | 61 | 118 | 329 | 5270 | 745 | 315 | 1.79 | 44.66 | |
95 | Pulmonary Pharmacology and Therapeutics | journal | 0.786 Q2 | 81 | 52 | 172 | 2317 | 532 | 169 | 3.26 | 44.56 | |
96 | Cardiovascular Therapeutics | journal | 0.769 Q2 | 54 | 34 | 165 | 1509 | 544 | 165 | 3.43 | 44.38 | |
97 | International Journal of Pharmaceutical Sciences and Nanotechnology | journal | 0.133 Q4 | 6 | 59 | 166 | 2606 | 56 | 163 | 0.32 | 44.17 | |
98 | Pharmaceutical Medicine | journal | 0.732 Q2 | 25 | 47 | 107 | 2050 | 275 | 93 | 2.59 | 43.62 | |
99 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.569 Q2 | 81 | 55 | 756 | 2389 | 1526 | 695 | 1.91 | 43.44 | |
100 | Vascular Health and Risk Management | journal | 0.647 Q2 | 82 | 86 | 224 | 3733 | 606 | 219 | 2.70 | 43.41 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®